Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma.
暂无分享，去创建一个
Michael L. Wang | Y. Oki | K. Nomie | Liang Zhang | L. Fayad | J. Westin | A. Desai | P. Lin | H. Lee | M. Fanale | F. Hagemeister | Haige Ye | Makhdum Ahmed | J. Romaguera | F. Samaniego | L. Nastoupil | J. Medeiros | M. Badillo | K. Hartig | M. Rodriguez | Lei Feng